690632-38-3

Basic information

• Product Name: TERT-BUTYL6-BROMO-4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,4'-PIPERIDINE!-1'-CARBOXY
• Synonyms: TERT-BUTYL6-BROMO-4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,4'-PIPERIDINE!-1'-CARBOXY;tert-Butyl 6-bromo-4-oxo-3,4-dihydro-1'H-spiro(chromene-2,4'-piperidine)-1'-carboxylate;tert-Butyl 6-broMo-4-oxospiro[chroMan-2,4'-piperidine]-1'-carboxylate;6-Bromo-3,4-dihydro-4-oxo-spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid tert-butyl ester;tert-butyl 6-bromo-4-oxospiro[chromane-2,4'-piperidine]-1'-carboxylate;6-bromo-3,4-dihydro-4-oxo-spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid 1,1-dimethylethyl ester;Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 6-bromo-3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester
• CAS NO: 690632-38-3
• Molecular Formula: C₁₈H₂₂BrNO₄
• Molecular Weight: 396.27558
• Mol File: 690632-38-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 501.3oC at 760 mmHg
• Flash Point: 257oC
• Appearance: /
• Density: 1.44
• Storage Temp.: 2-8°C
• CAS DataBase Reference: TERT-BUTYL6-BROMO-4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,4'-PIPERIDINE!-1'-CARBOXY(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL6-BROMO-4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,4'-PIPERIDINE!-1'-CARBOXY(690632-38-3)
• EPA Substance Registry System: TERT-BUTYL6-BROMO-4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,4'-PIPERIDINE!-1'-CARBOXY(690632-38-3)

Safety Data

• Hazardous Substances Data: 690632-38-3(Hazardous Substances Data)

Usage

General Description

Tert-butyl6-bromo-4-oxo-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxy is a chemical compound that belongs to the spirooxindole family. It contains a tert-butyl group, a bromine atom, and a piperidine ring with a spirochromene moiety. The compound is used in organic synthesis and medicinal chemistry, where it can act as a building block for the construction of complex molecules with potential pharmaceutical applications. Its unique structural features make it a valuable tool for the development of new drugs and biologically active compounds.

Upstream product

• 30186-18-6 4'-bromo-2'-hydroxyacetophenone 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 921760-77-2 3-{1'-tert-butoxycarbonyl-4-oxospiro[chroman-2,4'-piperidin]-6-yl}benzoic acid 
• 921760-47-6 tert-butyl 6-cyano-4-oxospiro[chroman-2,4'-piperidine]-1'-carboxylate 
• 921760-46-5 6-bromospiro[chroman-2,4'-piperidin]-4-one hydrochloride 
• 690632-08-7 6-bromospiro[chroman-2,4'-piperidin]-4-one 
• 1051383-07-3 6-benzyl 1'-tert-butyl 4-oxo-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1',6-dicarboxylate 
• 1192127-72-2 (E)-3-{1'-benzyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl}-N-(tetrahydro-pyran-2-yloxy)-acrylamide 
• 1192127-78-8 (E)-3-(1'-benzoyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl)-N-(tetrahydro-pyran-2-yloxy)-acrylamide 
• 1192127-70-0 (E)-3-{1'-benzyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl}-acrylic acid methyl ester 
• 1192127-76-6 (E)-3-{1'-benzoyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl}-acrylic acid methyl ester 
• 1192127-71-1 (E)-3-{1'-benzyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl}-acrylic acid 
• 1192127-77-7 (E)-3-{1'-benzoyl-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl}-acrylic acid 
• 1192125-79-3 (E)-N-hydroxy-3-{1'-benzyl-4-oxospiro[chromane-2,4'-piperidine]-6-yl}acrylamide hydrochloride 
• 1192125-81-7 (E)-N-hydroxy-3-{1'-benzoyl-4-oxospiro[chromane-2,4'-piperidine]-6-yl}acrylamide 
• 1192125-94-2 (E)-N-hydroxy-3-{1'-benzyl-4-hydroxyspiro[chromane-2,4'-piperidine]-6-yl}acrylamide 

Relevant articles and documents

N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof

N-sulfamoyl-N′-benzopyranpiperidine compounds of formula I and their physiologically acceptable acid addition salts, pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment and/or inhibition of glaucoma, epilepsy, bipolar disorders, migraine, neuropathic pain, obesity, type II diabetes, metabolic syndrome, alcohol dependence, and/or cancer, and related concomitant and/or secondary diseases or conditions.